Emerging reports suggest that the inflammatory and metabolic markers neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and De Ritis ratio (aspartate aminotransaminase [AST]/Alanine aminotransaminase [ALT]) may be associated with survival outcomes in RCC (5–9). Here, GPT is linked to renal cell carcinoma.